Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Veracyte stock crashed almost 40% early Thursday after the company reset growth expectations for its prostate cancer tissue test, Decipher.
The post Veracyte Crashes Almost 40% On Seismic Shift For Its Best-Selling Test appeared first on Investor’s Business Daily.